封面
市場調查報告書
商品編碼
1741366

肺癌手術市場:按產品類型、按手術類型、按程序、按癌症分期、按最終用戶、按地區

Lung Cancer Surgery Market, By Product Type, By Surgery Type, By Procedure, By Cancer Stage, By End user, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年肺癌手術市場規模估計為 66.1 億美元,預計到 2032 年將達到 90 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 4.5%。

分析範圍 分析詳細資訊
基準年 2024 市場規模(2025年) 66.1億美元
效能數據 2020-2024 預測期 2025-2032
預測期內的複合年成長率(2025-2032) 4.50% 預計金額(2032年) 90億美元

肺癌是一種起源於肺部的癌症。肺部是位於胸腔內的兩個類似海綿的器官,在人體吸氣時吸收氧氣,呼氣時會釋放二氧化碳。肺癌是全球最常見的癌症之一,也是癌症死亡的主要原因。

肺癌手術是一種切除腫瘤或受癌症影響的肺部區域的醫療程序。手術類型取決於腫瘤在肺部的大小和位置、肺癌的類型(非小細胞切除術或小細胞肺癌)以及患者的整體狀況。肺癌手術有幾種類型,包括肺葉切除術和切除術。肺癌手術是治療這種惡性疾病的關鍵方法。手術切除病變的肺組織使醫務人員能夠針對局部腫瘤,提供有效的治療和治癒的可能性。此手術的成功取決於早期發現、準確的分期和患者的整體狀況。從傳統的開放性手術到VATS(電視輔助胸腔手術)等微創技術,肺癌手術不斷發展,旨在最大限度地減少創傷並促進復原。肺癌手術仍然是多學科對抗肺癌的重要組成部分。

市場動態:

預計肺癌盛行率的上升將在預測期內推動全球肺癌手術市場的成長。例如,根據世界癌症研究基金會國際組織2022年3月發布的數據,2020年全球整體將新增超過220萬例肺癌新患者。

本報告的主要特點

  • 本報告對全球肺癌手術市場進行了詳細分析,並以 2024 年為基準年,展示了預測期(2025-2032 年)的市場規模和複合年成長率。
  • 它還強調了每個細分市場的潛在商機,並解釋了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球肺癌手術市場的主要企業是根據公司概況、產品系列、主要亮點、財務績效和策略等參數列出的。
  • 透過本報告的見解,負責人和企業經營團隊可以就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
  • 「全球肺癌手術市場」報告涉及該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球肺癌手術市場的各種策略矩陣來促進他們的決策。

目錄

第1章 分析目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map (COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
      • 肺癌發生率上升
    • 限制因素
      • 肺癌手術費用高昂
    • 機會
      • 採用微創技術
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

4. 全球肺癌手術市場:COVID-19感染疾病的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

第5章全球肺癌手術市場依產品類型(2020-2032)

  • 手術器械
  • 監控與視覺化系統
  • 內視鏡手術設備
  • 機器人輔助胸腔外科手術系統
  • 其他

6. 全球肺癌手術市場依手術類型(2020-2032)

  • 開放性手術
  • 微創手術

7. 全球肺癌手術市場(依程序分類)(2020-2032)

  • 切除術
  • 切除術/楔形切除術
  • 肺切除術
  • 袖狀切除術
  • 擴大切除術

8. 全球肺癌手術市場(依癌症分期分類)(2020-2032 年)

  • 早期
  • 後期

9. 全球肺癌手術市場(依最終用戶分類)(2020-2032 年)

  • 醫院
  • 門診手術中心
  • 專科診所

第 10 章 按地區分類的全球肺癌手術市場(2020-2032 年)

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第11章競爭格局

  • Ethicon(Johnson & Johnson)
  • Medtronic
  • Intuitive Surgical
  • Olympus Corporation
  • Karl Storz
  • Accuray Incorporated
  • AngioDynamics
  • Varian Medical Systems
  • Siemens Healthineers
  • Atricure, Inc.
  • Novadaq Technologies Inc.
  • GE Healthcare
  • Scanlan International Inc

第12章 章節

  • 分析方法
  • 關於出版商
簡介目錄
Product Code: CMI6146

Lung Cancer Surgery Market is estimated to be valued at USD 6.61 Bn in 2025 and is expected to reach USD 9.00 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.61 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.50% 2032 Value Projection: USD 9.00 Bn

Lung cancer is a type of cancer that begins in the lungs, which are two spongy organs in chest that take in oxygen when a person inhale and release carbon dioxide when a person exhale. It is one of the most common cancers in the world and is a leading cause of cancer deaths.

Lung cancer surgery is a medical procedure performed to remove a tumor or a portion of the lung affected by cancer. The type of surgery depends on the size and location of the tumor in the lung, the type of lung cancer (non-small cell or small cell lung cancer), and the patient's overall health. There are several types of lung cancer surgeries such as lobectomy, segmentectomy, etc. Lung cancer surgery stands as a pivotal approach to treating this aggressive disease. By surgically removing affected lung tissue, medical professionals can target localized tumors, offering a chance for effective treatment and the potential cure. The procedure's success relies on early detection, accurate staging, and the patient's overall health. From traditional open surgeries to minimally invasive techniques like VATS (Video-Assisted Thoracoscopic Surgery), lung cancer surgery has evolved to minimize trauma and enhance recovery. It remains a crucial component in the multidisciplinary battle against lung cancer.

Market Dynamics:

The increasing prevalence of lung cancer is expected to drive the growth of the global lung cancer surgery market over the forecast period. For instance, according to data published in March 2022 by the World Cancer Research Fund International, globally, there were more than 2.2 million new cases of lung cancer in 2020.

Key features of the study:

  • This report provides in-depth analysis of the global lung cancer surgery market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global lung cancer surgery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Ethicon (Johnson & Johnson), Medtronic, Intuitive Surgical, Olympus Corporation, Karl Storz, Accuray Incorporated, AngioDynamics, Varian Medical Systems, Siemens Healthineers, Atricure, Inc., Novadaq Technologies Inc., GE Healthcare and Scanlan International Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global lung cancer surgery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lung cancer surgery market

Lung cancer surgery market Detailed Segmentation:

  • By Product Type:
    • Surgical Instruments
    • Monitoring & Visualizing System
    • Endosurgical Equipment
    • Robotic-Assisted Thoracic Surgery Systems
    • Others
  • By Surgery Type:
    • Open Surgery
    • Minimally Invasive Surgery
  • By Procedure:
    • Lobectomy
    • Segmentectomy/Wedge Resection
    • Pneumonectomy
    • Sleeve Resection
    • Extended Resection
  • By Cancer Stage:
    • Early-Stage
    • Advanced-Stage
  • By End user:
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
  • By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profile:
    • Ethicon (Johnson & Johnson)
    • Medtronic
    • Intuitive Surgical
    • Olympus Corporation
    • Karl Storz
    • Accuray Incorporated
    • AngioDynamics
    • Varian Medical Systems
    • Siemens Healthineers
    • Atricure, Inc.
    • Novadaq Technologies Inc.
    • GE Healthcare
    • Scanlan International Inc

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Lung Cancer Surgery, By Surgery Type
    • Market Lung Cancer Surgery, By Product Type
    • Market Lung Cancer Surgery, By Procedure
    • Market Lung Cancer Surgery, By Cancer Stage
    • Market Lung Cancer Surgery, By End User
    • Market Lung Cancer Surgery , By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of lung cancer
    • Restraints
  • High Cost of Lung Cancer Surgery
    • Opportunities
  • Adoption of Minimally Invasive Techniques
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Lung Cancer Surgery Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Lung Cancer Surgery Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Surgical Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Monitoring & Visualizing System
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Endosurgical Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Robotic-Assisted Thoracic Surgery Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Lung Cancer Surgery Market, By Surgery Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Open Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Minimally Invasive Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Lung Cancer Surgery Market, By Procedure, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Lobectomy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Segmentectomy/Wedge Resection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Pneumonectomy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Sleeve Resection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Extended Resection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )

8. Global Lung Cancer Surgery Market, By Cancer Stage, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Early-Stage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Advanced-Stage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Lung Cancer Surgery Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )

10. Global Lung Cancer Surgery Market, By Geography, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2020 - 2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

11. Competitive Landscape

  • Ethicon (Johnson & Johnson)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Intuitive Surgical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Olympus Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Karl Storz
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Accuray Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • AngioDynamics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Varian Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Atricure, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novadaq Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Scanlan International Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

12. Section

  • Research Methodology
  • About us